Xiao-Fan Wang

Advisor at TCRCure Biopharma

Prof. Wang has made important contributions to cancer-related fields such as cell signal transduction, DNA damage and repair, and tumor microenvironment. He was the first to clone the TGF-β type II and type III receptors, which was an important discovery and had a profound impact on the subsequent research of TGF-β. He also determined several important regulatory factors and mechanisms of the TGF-β pathway, which are critical to the current understanding of the tumor microenvironment. Prof. Wang published more than 20 papers in high-profile journals including Cell, Nature, Science, Genes and Development, P.N.A.S.

Since 2006, he has served as the deputy editor-in-chief of the Journal of Biological Chemistry. During his tenure as editor-in-chief, he introduced dozens of Chinese science and technology leaders to advocate for the impact of Chinese scientists to the global community. Since 2007, he has served as a member of the Overseas Expert Advisory Committee of China. In 2010, he was appointed as a member of the scientific board of the Ministry of Science and Technology and has participated in many reforms of Chinese science policies. In order to help establish an academic evaluation system in China, Prof. Wang organized a team of experts from more than 10 top life science research institutes including the Chinese Academy of Sciences, Tsinghua University, Peking University, Zhejiang University Life, and other universities.

Timeline

  • Advisor

    Current role